Swine influenza
MONDO:0005460An acute viral respiratory infection caused by a strain of influenza virus which is endemic in swine (pigs). Rarely reported in humans prior to 2009, the disease is caused by a mutated strain of swine influenza A (H1N1) virus. It is highly contagious and spreads mainly through coughing and sneezing. Signs and symptoms include fever, chills, coughing, sore throat headache, muscle ache, and generalized weakness. Antiviral medications are most effective in the first two days of the illness.
Also known as: H1N1 Influenza, H1N1 Virus infection, H1N1 flu, Influenza A (H1N1), Influenza A (H1N1) Virus infection, Swine influenza virus caused influenza, Swine influenza virus influenza, swine flu
92 clinical trials for this condition and its sub-types, 35 tagged with Swine influenza itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New universal flu vaccine enters human testing
Vaccine Recruiting nowThis study tests an experimental flu vaccine called BPL-1357, given as a shot or nasal spray, to see if it is safe and can protect against multiple flu types. About 129 healthy adults aged 18-55 will receive the vaccine or a placebo, then be exposed to a flu virus in a controlled…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New vaccines for RSV and bird flu enter human testing
Vaccine Recruiting nowThis early-stage trial is testing several new vaccine formulas against RSV and H5N1 bird flu in 570 healthy adults aged 18 to 49. The main goals are to check safety and see how well the vaccines trigger an immune response. Participants will receive one or two shots and be followe…
Phase 1 • Sponsor: Sanofi • Aim: Vaccine
Last updated Jun 27, 2026 12:30 UTC
-
Can a digital swab test tell COVID and flu apart at home?
Diagnosis Recruiting nowThis study evaluates a new digital test that people can use at home to detect COVID-19 and influenza A and B from a nasal swab. Participants with symptoms will use the test themselves and compare the results to a standard lab PCR test. The goal is to see if the test is accurate e…
Sponsor: Biocrucible Ltd • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Could a single pill shorten the flu? new trial aims to find out
Symptom relief Recruiting nowThis phase 3 trial tests whether a single dose of baloxavir helps non-hospitalized adults with mild-to-moderate influenza recover faster compared to a placebo. About 264 participants will be enrolled within 5 days of symptoms and tracked until they feel fully recovered. The study…
Phase 3 • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
New flu pill for teens shows promise in Late-Stage trial
Symptom relief Recruiting nowThis study tests a new flu medicine called onradivir in teenagers aged 12 to 17 with uncomplicated influenza A. About 150 teens will receive either the drug or a placebo for 5 days. Researchers will track how fast flu symptoms like fever and body aches go away, and check for side…
Phase 3 • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Scientists hunt for clues in COVID Patients' blood and secretions
Knowledge-focused Recruiting nowThis study collects blood and nasal secretions from up to 2,000 people with COVID-19 to learn why some get very sick while others recover easily. Researchers will also track long-term symptoms like fatigue and brain fog. No treatments are tested—the goal is to gather data to guid…
Sponsor: Tulane University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC